Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in mild Graves' ophthalmopathy
NCT02535975Unknown
- Sponsor
- Yonsei University
- Start
- Dec 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs) in Graves' ophthalmopathy (TED) (2 arms), sponsored by Yonsei University. Primary endpoints: Clinical Activity Score at 12 months and NOSPECS Score at 12 months. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NCT02535975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535975.